LifeLabs is a Canadian-owned healthcare company that has been in business for over 50 years. LifeLabs has a national collection network that streamlines specimen procurement and sample submission, simplifying the testing process for both healthcare provider and patient.
LifeLabs hereditary cancer panel offers a pan-cancer screening approach that includes full sequencing and copy number variant analyses of 84 of the more common genes associated with increased risk of developing hereditary breast, ovarian, uterine, colorectal, gastric, prostate, melanoma, and pancreatic cancer. Pre- and post-test genetic counselling is included in the testing.
The cost of the test will either be $600 or $950 (Canadian dollars), depending on the panel selected
Genetic testing for various cancers, such as breast, colon and prostate.
We use cookies to improve your experience on our site. Learn more.
We use cookies to enhance your browsing experience and enable essential functions on our website. Some cookies are categorised as "Necessary" are automatically stored on your browser as they are crucial for the basic operation of the site - they can no be adjusted using these tools. Additionally, we use third-party cookies to help us analyse your usage of the website. These cookies are stored in your browser only with your prior consent. You have the option to enable or disable some or all of these cookies.